Vantage logo

China comes of age

Chi-Med is not alone in seeing Chinese approval as the prelude to a regulatory green light in the west.

Vantage logo

Where is the IPO class of 2014-15 now?

A golden age for biotech flotations yielded some spectacular blow-ups, but also saw several groups reward investors with premium-priced takeovers.